Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 649-660 of 2,301
Drug study icon
CompletedNCT07549581

SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

This study is completed in the United States. It is testing SEP-380135 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, Schizophrenia, ...DrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression, Schizophrenia, ...
Device study icon
CompletedNCT06772987

NQ TMS for MDD Therapy Using 1 Day x 3 Sessions Protocol for Adult Patient

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 85 Years
Countries
United States
Sponsor
NeuroQore Inc.
Condition
Depression
Drug study icon
CompletedNCT04032301

Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, PTSDDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Depression, PTSD
Device study icon
TerminatedNCT06462820

SAINT for MDD in an Inpatient Setting Follow-on

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDeviceFrom 18 Years to 75 Years
Countries
United States
Sponsor
Magnus Medical
Condition
Depression, Suicidality
Drug study icon
CompletedNCT03039192

Intranasal Esketamine for depression

This study is completed in the United States, in Bulgaria, in Estonia, .... It is testing intranasal Esketamine for depression.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 64 Years
Countries
United States, Bulgaria, Estonia, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
CompletedNCT03097133

Intranasal Esketamine for depression

This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine for depression.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
TerminatedNCT05109195

A Standard of Care Study of people with Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

This study was terminated in the United States and in the United Kingdom. It focuses on depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 74 Years
Countries
United States, United Kingdom
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
TerminatedNCT06635135

Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression

This study was terminated in the United States, in France, in Belgium, .... It is testing aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States, France, Belgium, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
TerminatedNCT03352453

Rapastinel for depression

This study was terminated in the United States. It is testing rapastinel for depression.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Naurex, Inc, an affiliate of Allergan plc
Condition
Depression, Suicidality
Drug study icon
TerminatedNCT04951609

Seltorexant for depression

This study was terminated in the United States, in the United Kingdom, in Italy, .... It is testing seltorexant for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 12 Years to 17 Years
Countries
United States, United Kingdom, Italy, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT04533529

Seltorexant for depression

This study is completed in the United States, in Brazil, in Bulgaria, .... It is testing seltorexant for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Brazil, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
TerminatedNCT04532749

Seltorexant for depression

This study was terminated in the United States, in Argentina, in Chile, .... It is testing seltorexant for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.